DWP
GILD icon

Daymark Wealth Partners’s Gilead Sciences GILD Stock Holding History

Daymark Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.86M Sell
30,546
-539
-2% -$71K 0.09% 166
2026
Q1 		$4.33M Sell
31,085
-824
-3% -$115K 0.14% 133
2025
Q4 		$3.92M Buy
31,909
+735
+2% +$89.3K 0.12% 131
2025
Q3 		$3.46M Buy
31,174
+2,114
+7% +$240K 0.12% 146
2025
Q2 		$3.22M Buy
29,060
+25
+0.1% +$2.66K 0.12% 143
2025
Q1 		$3.25M Sell
29,035
-1,855
-6% -$191K 0.14% 128
2024
Q4 		$2.85M Sell
30,890
-211
-0.7% -$19K 0.12% 136
2024
Q3 		$2.61M Sell
31,101
-4
-0% -$305 0.11% 145
2024
Q2 		$2.13M Sell
31,105
-6,518
-17% -$435K 0.1% 155
2024
Q1 		$2.76M Buy
37,623
+19
+0.1% +$1.46K 0.15% 110
2023
Q4 		$3.05M Buy
37,604
+4,577
+14% +$356K 0.19% 98
2023
Q3 		$2.48M Buy
33,027
+6,854
+26% +$527K 0.17% 106
2023
Q2 		$2.02M Buy
26,173
+7,149
+38% +$570K 0.15% 119
2023
Q1 		$1.58M Buy
19,024
+523
+3% +$43.3K 0.21% 94
2022
Q4 		$1.59M Buy
+18,501
New +$1.47M 0.28% 73

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Daymark Wealth Partners's GILD Position: Q2 2026 in Review

Daymark Wealth Partners reduced its Gilead Sciences (GILD) stake by 1.7% in Q2 2026, selling an estimated $71K and leaving 30,546 shares worth $3.86M. The position accounts for 0.09% of the portfolio, ranked #166.

Daymark Wealth Partners first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.33M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Daymark Wealth Partners held 30,546 shares of Gilead Sciences worth $3.86M as of Q2 2026.
  • Daymark Wealth Partners sold 539 Gilead Sciences shares in Q2 2026, an estimated $71K.
  • Gilead Sciences made up 0.09% of Daymark Wealth Partners's portfolio in Q2 2026, its #166 holding.
  • Daymark Wealth Partners first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Daymark Wealth Partners's Gilead Sciences position peaked at $4.33M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.